1. Home
  2. RPC vs SLBT Comparison

RPC vs SLBT Comparison

Compare RPC & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ridgepost Capital Inc. Class A Common Stock

RPC

Ridgepost Capital Inc. Class A Common Stock

N/A

Current Price

$7.50

Market Cap

960.2M

Sector

Finance

ML Signal

N/A

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

N/A

Current Price

$1.66

Market Cap

942.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RPC
SLBT
Founded
1992
N/A
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
960.2M
942.1M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
RPC
SLBT
Price
$7.50
$1.66
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $12.75
N/A
AVG Volume (30 Days)
★ 480.4K
108.5K
Earning Date
11-12-2026
N/A
Dividend Yield
★ 2.15%
N/A
EPS Growth
★ 6.25
N/A
EPS
★ 0.14
N/A
Revenue
★ $297,346,000.00
N/A
Revenue This Year
$20.02
N/A
Revenue Next Year
$16.79
N/A
P/E Ratio
$52.44
★ N/A
Revenue Growth
★ 0.30
N/A
52 Week Low
$6.79
$1.42
52 Week High
$9.51
$6.25

Technical Indicators

Market Signals
Indicator
RPC
SLBT
Relative Strength Index (RSI) 39.95 35.86
Support Level $7.54 N/A
Resistance Level $8.02 $3.36
Average True Range (ATR) 0.23 0.18
MACD -0.03 0.02
Stochastic Oscillator 39.47 32.89

Price Performance

Historical Comparison
RPC
SLBT

About RPC Ridgepost Capital Inc. Class A Common Stock

Ridgepost Capital Inc, formelrly P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue mainly comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

Share on Social Networks: